Risk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function

Diabetes

Volumn 63, Issue 7, 2014, Pages 2506-2515

  Jin, Yulan ^a,b   Sharma, Ashok ^b   Bai, Shan ^b   Davis, Colleen ^b   Liu, Haitao ^a,b   Hopkins, Diane ^b   Barriga, Kathy ^c   Rewers, Marian ^c   She, Jin Xiong ^a,b  

^a NANJING TECH UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL CYCLE PROTEIN 20; INITIATION FACTOR 3; INSULIN ANTIBODY; PEROXIREDOXIN 5;

ANKRD9 GENE; ARTICLE; BACH2 GENE; CHCHD5 GENE; CHILD; DOCK8 GENE; ESAM GENE; ETS2 GENE; FEMALE; FKBP11 GENE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; ITGB5 GENE; KHDRBS1 GENE; LHPP GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MAP2K1 GENE; MICROARRAY ANALYSIS; NFE2 GENE; ORM1 GENE; PANCREAS ISLET; PERIPHERAL BLOOD MONONUCLEAR CELL; PLD3 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNF167 GENE; TMEM91 GENE; TRAPPC5 GENE; TSC1 GENE; TXNDC5 GENE; UBP1 GENE; XRCC2 GENE;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; RISK; YOUNG ADULT;

EID: 84903183608     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1716     Document Type: Article

References (38)

1. Knip M, Korhonen S, Kulmala P, et al. Prediction of type 1 diabetes in the general population. Diabetes Care 2010;33:1206-1212
2. Wenzlau JM, Hutton JC. Novel diabetes autoantibodies and prediction of type 1 diabetes. Curr Diab Rep 2013;13:608-615
3. Skyler JS. Prediction and prevention of type 1 diabetes: progress, problems, and prospects. Clin Pharmacol Ther 2007;81:768-771 (Pubitemid 46625122)
4. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309:2473-2479
5. Steck AK, Johnson K, Barriga KJ, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 2011;34:1397-1399
6. Lipponen K, Gombos Z, Kiviniemi M, et al. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 2010;59:3253-3256
7. Mbunwe E, Van der Auwera BJ, Vermeulen I, et al.; Belgian Diabetes Registry. HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients. Diabetes 2013;62:1345-1350
8. Mrena S, Virtanen SM, Laippala P, et al. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 2006;29:662-667 (Pubitemid 44115370)
9. Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of b-cell autoimmunity. Diabetes 2012;61:963-966
10. Bonifacio E, Krumsiek J, Winkler C, Theis FJ, Ziegler AG. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol. 19 November 2013 [Epub ahead of print]
11. Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 2013;56:1615-1622
12. Winkler C, Krumsiek J, Lempainen J, et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun 2012;13:549-555
13. Sosenko JM, Krischer JP, Palmer JP, et al.; Diabetes Prevention Trial-Type 1 Study Group. A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2008;31:528-533
14. Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP; DPT-1 Study Group. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes Care 2012;35:1975-1980
15. Xu P, Wu Y, Zhu Y, et al.; Diabetes Prevention Trial-Type 1 (DPT-1) Study Group. Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care 2010;33:2508-2513
16. Elo LL, Mykkänen J, Nikula T, et al. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. J Autoimmun 2010;35:70-76
17. Han D, Cai X, Wen J, et al. Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes. Clin Exp Immunol 2012;170:131-138
18. Jin Y, She JX. Novel biomarkers in type 1 diabetes. Rev Diabet Stud 2012;9:224-235
19. Jin Y, Sharma A, Carey C, et al. The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes. Diabetes Care 2013;36:2794-2802
20. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007;92:3705-3711 (Pubitemid 47435359)
21. Padmos RC, Schloot NC, Beyan H, et al.; LADA Consortium. Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes 2008;57:2768-2773
22. Reynier F, Pachot A, Paye M, et al. Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun 2010;11:269-278
23. Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996;39:807-812 (Pubitemid 26228110)
24. Kohonen T. Essentials of the self-organizing map. Neural Netw 2013;37:52-65
25. Hagopian WA, Lernmark A, Rewers MJ, et al. TEDDY-The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann N Y Acad Sci 2006;1079:320-326 (Pubitemid 44968741)
26. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-1076 (Pubitemid 40616615)
27. Skyler JS, Greenbaum CJ, Lachin JM, et al.; Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet - an international collaborative clinical trials network. Ann N Y Acad Sci 2008;1150:14-24
28. Bauer TR Jr., McDermid HE, Budarf ML, Van Keuren ML, Blomberg BB. Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2. Immunogenetics 1993;38:387-399 (Pubitemid 23290965)
29. Muto A, Ochiai K, Kimura Y, et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J 2010;29:4048-4061
30. Hutchings P, Tonks P, Cooke A. Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes 1997;46:779-784 (Pubitemid 27188254)
31. Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008;40:1399-1401
32. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-1125
33. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42:295-302
34. Sawcer S, Hellenthal G, Pirinen M, et al.; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-219
35. Jin Y, Birlea SA, Fain PR, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 2012;44:676-680
36. Saletta F, Suryo Rahmanto Y, Richardson DR. The translational regulator eIF3a: the tricky eIF3 subunit! Biochim Biophys Acta 2010;1806:275-286
37. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007;27:3-16 (Pubitemid 46991390)
38. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem 1979;254:9627-9632 (Pubitemid 10248727)